Russell Investments Group
RNAC icon

Russell Investments Group’s Cartesian Therapeutics RNAC Stock Holding History

Russell Investments Group’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.22K Hold
849
– – ﹤0.01% 3885
2025
Q4 		$6.12K Buy
849
+82
+11% +$663 ﹤0.01% 3878
2025
Q3 		$7.84K Buy
767
+712
+1,295% +$8K ﹤0.01% 3836
2025
Q2 		$571 Buy
+55
New +$586 ﹤0.01% 3734
2024
Q3 		– Sell
-152
Closed -$4.11K – 3781
2024
Q2 		$4.11K Buy
152
+145
+2,071% +$3.46K ﹤0.01% 3258
2024
Q1 		$137 Hold
7
– – ﹤0.01% 3290
2023
Q4 		$145 Sell
7
-564
-99% -$16.8K ﹤0.01% 3189
2023
Q3 		$18.2K Sell
571
-979
-63% -$32.7K ﹤0.01% 2900
2023
Q2 		$52.1K Buy
1,550
+56
+4% +$2K ﹤0.01% 2719
2023
Q1 		$62.3K Sell
1,494
-31
-2% -$1.46K ﹤0.01% 2680
2022
Q4 		$51.7K Sell
1,525
-37
-2% -$1.57K ﹤0.01% 2735
2022
Q3 		$76K Sell
1,562
-290
-16% -$15.9K ﹤0.01% 2706
2022
Q2 		$72K Sell
1,852
-462
-20% -$13.7K ﹤0.01% 2704
2022
Q1 		$84K Sell
2,314
-1,701
-42% -$106K ﹤0.01% 2585
2021
Q4 		$391K Sell
4,015
-2,552
-39% -$275K ﹤0.01% 2520
2021
Q3 		$817K Sell
6,567
-3,028
-32% -$366K ﹤0.01% 2275
2021
Q2 		$1.2M Sell
9,595
-955
-9% -$114K ﹤0.01% 2223
2021
Q1 		$1.43M Buy
10,550
+6,411
+155% +$796K ﹤0.01% 2070
2020
Q4 		$376K Buy
4,139
+3,861
+1,389% +$335K ﹤0.01% 2542
2020
Q3 		$20K Hold
278
– – ﹤0.01% 3137
2020
Q2 		$23K Buy
+278
New +$25.2K ﹤0.01% 3047

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's RNAC Position: Q1 2026 in Review

Russell Investments Group held its Cartesian Therapeutics (RNAC) position steady in Q1 2026 at 849 shares worth $5.22K. The position accounts for ﹤0.01% of the portfolio, ranked #3885.

Russell Investments Group first reported a position in RNAC in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.43M in Q1 2021. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • Russell Investments Group held 849 shares of Cartesian Therapeutics worth $5.22K as of Q1 2026.
  • Russell Investments Group left its Cartesian Therapeutics share count unchanged in Q1 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3885 holding.
  • Russell Investments Group first reported a position in Cartesian Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • Russell Investments Group's Cartesian Therapeutics position peaked at $1.43M in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.